Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Insight Team

Latest From Medtech Insight Team

Publisher’s Spotlight: Citeline News And Insights App

Introducing the all-new Citeline News and Insights app, providing seamless access to all your favorite award-winning publications. Explore the latest articles from Pink Sheet, Scrip, In Vivo, Medtech Insight, Generics Bulletin and HBW Insight, all in one stylish, intuitive and user-friendly platform.

Medical Device

ESG In 2024: Stakeholder Views From ‘Strategic Imperative’ To ‘Largely A Nonsense’

Medtech Insight and HBW Insight reached out to industry stakeholders for feedback on new climate-related disclosure requirements and growing environmental, social and governance (ESG) pressures on businesses.

Regulation Sustainability

ESG In 2024: Stakeholder Views From ‘Strategic Imperative’ To ‘Largely A Nonsense’

HBW Insight and Medtech Insight reached out to industry stakeholders for feedback on new climate-related disclosure requirements and growing environmental, social and governance (ESG) pressures on businesses.

Regulation Sustainability

'Blah-Blah' May Subside, But Harnessing AI Ethically, Impactfully Is Key For Medtech In 2024

Views from medtech industry leaders and investors on the most significant uncertainties and opportunities facing the sector in 2024. 

Artificial Intelligence Cybersecurity

FDA’s LDT Proposal, AI Oversight, Cybersecurity Top US Regulatory Interests In 2024

Views from industry experts and the US FDA on priorities and regulatory topics to watch in 2024. 

Regulation Legal Issues
See All
UsernamePublicRestriction

Register